Company News
Strides Pharma Board Meeting for Q2 FY27 Results
Strides Pharma board meeting scheduled for October 29, 2026 to approve unaudited Q2 and H1 FY27 financial results.
Trading window for designated persons closed from October 1, 2026 until 48 hours afte
